Inventor · disambiguated record
Michael L. Cappola
Also filed as: CAPPOLA MICHAEL · CAPPOLA MICHAEL L
10 granted patents·4 pending applications·137 citations·filing 1998–2011
89Inventor score
Top patents by PatentIndex Score
14 records- 0187US6267310B1Process for separating particles of cohesive material according to sizeBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Jul 31, 2001·34 cites·4 claims
- 0285US6753012B2Method for coating pharmaceutical dosage formsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jun 22, 2004·17 cites·3 claims
- 0384US6254888B1Method for coating pharmaceutical dosage formsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Jul 3, 2001·15 cites·10 claims
- 0483US6036126AApparatus for separating particles of cohesive material according to size and processBOEHRINGER INGELHEIM PHARMA·Filed 1998·Granted Mar 14, 2000·45 cites·4 claims
- 0578US6562871B1Dry granulation of pharmaceutical formulation comprising mexiletineBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 13, 2003·8 cites·2 claims
- 0673US6503535B2Method for coating pharmaceutical dosage formsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jan 7, 2003·3 cites·18 claims
- 0770US6808721B2Methods for coating pharmaceutical core tabletsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Oct 26, 2004·4 cites·12 claims
- 0870US6565880B2Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-ureaBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 20, 2003·8 cites·18 claims
- 0961US8785418B2Lyophilization cakes of proteasome inhibitorsBRICOUT DENIS·Filed 2011·Granted Jul 22, 2014·3 cites·17 claims
- 1047US2007099832A1Combination Therapy with p38 MAP Kinase Inhibitors and their Pharmaceutical CompositionsSIMIANER STEFAN·Filed 2006·Application pending·0 cites
- 1146US2004110755A1Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1246US2003068340A1Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-ureaBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 1342US8460704B2Extended release formulation of nevirapineCAPPOLA MICHAEL L·Filed 2008·Granted Jun 11, 2013·0 cites·1 claims
- 1439US2003230004A1Batch fluid bed processorBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael L. Cappola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →